(OI) O-I Glass - Ratings and Ratios
Glass, Bottles, Jars, Containers, Packaging
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 42.9% |
| Value at Risk 5%th | 66.2% |
| Relative Tail Risk | -6.11% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.35 |
| Alpha | -5.32 |
| CAGR/Max DD | -0.09 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.502 |
| Beta | 0.962 |
| Beta Downside | 0.807 |
| Drawdowns 3y | |
|---|---|
| Max DD | 58.96% |
| Mean DD | 33.88% |
| Median DD | 40.21% |
Description: OI O-I Glass November 11, 2025
O-I Glass, Inc. (NYSE: OI) manufactures and sells a broad portfolio of glass containers for food, beverage, and pharmaceutical customers across the Americas, Europe, and other international markets. Its product line spans a variety of sizes, shapes, and colors, serving alcoholic drinks (beer, spirits, wine), non-alcoholic beverages (soft drinks, tea, juice), and food packaging, with sales delivered through direct supply contracts and distributor networks. The company traces its roots to 1903 and is headquartered in Perrysburg, Ohio.
Key operational metrics from the most recent fiscal year show revenue of approximately $5.4 billion and an adjusted EBITDA margin near 13 %, reflecting stable pricing power despite volatile raw-material (silica sand) costs. O-I’s growth is closely tied to macro-drivers such as the premium-beverage trend, which has boosted demand for high-clarity, recyclable glass, and tightening sustainability regulations that favor glass over plastic. The firm has announced a $250 million capital-expenditure program aimed at expanding its recycling capacity and modernizing production lines, positioning it to capture incremental volume as global recycling rates improve.
For a data-driven deep-dive into O-I’s valuation sensitivities and scenario analysis, consider exploring the company’s profile on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income (-145.0m TTM) > 0 and > 6% of Revenue (6% = 387.3m TTM) |
| FCFTA 0.02 (>2.0%) and ΔFCFTA 3.75pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 10.33% (prev 7.98%; Δ 2.35pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.06 (>3.0%) and CFO 516.0m > Net Income -145.0m (YES >=105%, WARN >=100%) |
| Net Debt (4.56b) to EBITDA (771.0m) ratio: 5.91 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.33 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (155.2m) change vs 12m ago 0.39% (target <= -2.0% for YES) |
| Gross Margin 16.84% (prev 15.99%; Δ 0.85pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 69.30% (prev 70.87%; Δ -1.57pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 0.88 (EBITDA TTM 771.0m / Interest Expense TTM 343.0m) >= 6 (WARN >= 3) |
Altman Z'' 0.79
| (A) 0.07 = (Total Current Assets 2.66b - Total Current Liabilities 1.99b) / Total Assets 9.26b |
| (B) 0.07 = Retained Earnings (Balance) 686.0m / Total Assets 9.26b |
| (C) 0.03 = EBIT TTM 301.0m / Avg Total Assets 9.31b |
| (D) -0.13 = Book Value of Equity -1.03b / Total Liabilities 7.79b |
| Total Rating: 0.79 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 37.72
| 1. Piotroski 2.0pt |
| 2. FCF Yield 2.55% |
| 3. FCF Margin 2.62% |
| 4. Debt/Equity 3.86 |
| 5. Debt/Ebitda 5.91 |
| 6. ROIC - WACC (= -0.50)% |
| 7. RoE -12.20% |
| 8. Rev. Trend -31.34% |
| 9. EPS Trend -36.27% |
What is the price of OI shares?
Over the past week, the price has changed by +2.97%, over one month by +17.63%, over three months by +9.90% and over the past year by +14.43%.
Is OI a buy, sell or hold?
- Strong Buy: 5
- Buy: 2
- Hold: 3
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the OI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 16.7 | 20.1% |
| Analysts Target Price | 16.7 | 20.1% |
| ValueRay Target Price | 14 | 0.6% |
OI Fundamental Data Overview December 03, 2025
P/E Forward = 7.278
P/S = 0.3186
P/B = 1.5603
P/EG = 0.3468
Beta = 0.804
Revenue TTM = 6.46b USD
EBIT TTM = 301.0m USD
EBITDA TTM = 771.0m USD
Long Term Debt = 4.95b USD (from longTermDebt, last quarter)
Short Term Debt = 170.0m USD (from shortTermDebt, last quarter)
Debt = 5.12b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.56b USD (from netDebt column, last quarter)
Enterprise Value = 6.62b USD (2.06b + Debt 5.12b - CCE 556.0m)
Interest Coverage Ratio = 0.88 (Ebit TTM 301.0m / Interest Expense TTM 343.0m)
FCF Yield = 2.55% (FCF TTM 169.0m / Enterprise Value 6.62b)
FCF Margin = 2.62% (FCF TTM 169.0m / Revenue TTM 6.46b)
Net Margin = -2.25% (Net Income TTM -145.0m / Revenue TTM 6.46b)
Gross Margin = 16.84% ((Revenue TTM 6.46b - Cost of Revenue TTM 5.37b) / Revenue TTM)
Gross Margin QoQ = 18.15% (prev 17.53%)
Tobins Q-Ratio = 0.71 (Enterprise Value 6.62b / Total Assets 9.26b)
Interest Expense / Debt = 1.84% (Interest Expense 94.0m / Debt 5.12b)
Taxrate = 36.21% (21.0m / 58.0m)
NOPAT = 192.0m (EBIT 301.0m * (1 - 36.21%))
Current Ratio = 1.33 (Total Current Assets 2.66b / Total Current Liabilities 1.99b)
Debt / Equity = 3.86 (Debt 5.12b / totalStockholderEquity, last quarter 1.33b)
Debt / EBITDA = 5.91 (Net Debt 4.56b / EBITDA 771.0m)
Debt / FCF = 26.98 (Net Debt 4.56b / FCF TTM 169.0m)
Total Stockholder Equity = 1.19b (last 4 quarters mean from totalStockholderEquity)
RoA = -1.57% (Net Income -145.0m / Total Assets 9.26b)
RoE = -12.20% (Net Income TTM -145.0m / Total Stockholder Equity 1.19b)
RoCE = 4.91% (EBIT 301.0m / Capital Employed (Equity 1.19b + L.T.Debt 4.95b))
RoIC = 3.07% (NOPAT 192.0m / Invested Capital 6.25b)
WACC = 3.58% (E(2.06b)/V(7.17b) * Re(9.56%) + D(5.12b)/V(7.17b) * Rd(1.84%) * (1-Tc(0.36)))
Discount Rate = 9.56% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.32%
[DCF Debug] Terminal Value 63.92% ; FCFE base≈169.0m ; Y1≈111.0m ; Y5≈50.7m
Fair Price DCF = 5.14 (DCF Value 789.6m / Shares Outstanding 153.6m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -36.27 | EPS CAGR: 7.97% | SUE: 0.27 | # QB: 0
Revenue Correlation: -31.34 | Revenue CAGR: 1.08% | SUE: -0.07 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.41 | Chg30d=-0.001 | Revisions Net=+0 | Analysts=7
EPS next Year (2026-12-31): EPS=1.95 | Chg30d=+0.062 | Revisions Net=+2 | Growth EPS=+21.1% | Growth Revenue=+2.0%
Additional Sources for OI Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle